We designed a specific inhibitor DBD15-21-22 for these dynamic water pockets, with the aim to lock the KRAS-G12D in the “off” (inactive) state, i.e., when the protein is unable to perform signaling processes and eventually develops cancer. Here, KRAS is linked to cancer.